Genentech stories

Sep 25, 2026

Genentech inks $1.5 billion bispecific antibody deal with Earendil Labs

Roche's Genentech is paying Earendil Labs $55 million upfront in a research collaboration to discover and develop multiple bispecific antibody cancer therapies. The oncology-focused deal includes milestone payments that could bring its total value to over $1.5 billion.

Sep 25, 20264 sources

Apr 7, 2026

FDA Supports Proposals to Incentivize Domestic Drug Manufacturing

The FDA has backed proposals in the Trump administration's budget aimed at encouraging pharmaceutical companies to test and manufacture drugs domestically, including potential tariffs and incentives.

Apr 7, 20262 sources